PLASMAONE™ is a cold plasma technology designed for a wide range of users in a large number of areas of conventional and regenerative medicine as well as regenerative aesthetics. The innovative cold atmospheric plasma therapy is non-invasive and painless, making it attractive and convenient for patients and easy to use for a wide range of medical conditions.
The technology uses cold atmospheric plasma. This causes no thermal damage to the tissue. There are two ways to generate cold plasma:
Direct cold plasma (PLASMAONE™): It is generated between a dielectric (insulating material) and the body, with human skin or tissue serving as the electrode. Thus, the plasma is created directly on the treatment area.
Indirect cold plasma (Plasmajet®): It is generated between two electrodes in the device and then delivered to the treatment area by a cooled flow of gas. This allows for a more controlled and targeted application.
The technology is designed for a wide range of patients in the following areas of medicine:
PlasmaOne™ technology therapy has been proven to achieve up to 99.9% reduction in microbes, significantly improve blood supply and thus accelerate healing of e.g. wounds and provide painless, non-invasive treatment.
PlasmaOne™ technology induces various beneficial biological effects in healing:
A number of patient benefits make PlasmaOne an attractive choice for a variety of medical and aesthetic conditions. Key benefits include:
The treatment does not disrupt tissue integrity, reducing the risk of complications associated with more invasive procedures.
PlasmaOne is designed to deliver pain-free treatments, improving convenience for patients. This aspect is particularly useful in most areas where anesthesia is not administered, where sensitivity to pain can be a significant point of concern.
The application of cold atmospheric plasma can significantly accelerate the wound healing process, especially on difficult to heal wounds, stimulating tissue regeneration and activating cellular activities necessary for regeneration of damaged tissues.
PlasmaOne technology can achieve up to 99.9% reduction in infectious agents (bacteria, viruses, fungi), making it extremely effective for sterilizing treatment areas and preventing the spread of infections, which is essential when treating chronic tissue disease conditions.
PlasmaOne can be used in all areas of medicine that deal with disruption of tissue integrity and functionality, especially in combination with an infectious component, including dermatology, gynecology, surgery, demonstrating its broad applicability.
The combination of non-invasive, painless and effective in its results treatment contributes to high patient satisfaction rates.
These benefits position PlasmaOne as a valuable tool in modern medical treatments, offering a blend of patient convenience and clinical effectiveness.
No risks have been identified. For your safety and comfort, you will first undergo an examination and consultation with our qualified specialist before beginning treatment with PlasmaOne.
PlasmaOne non-invasively and painlessly improve your quality of life.
